Alutard SQ / ALK-Abello - LARVOL DELTA

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma (clinicaltrials.gov) - P1/2 | N=36 | Not yet recruiting | Sponsor: University of Zurich

New P1/2 trial • Allergic Rhinitis • Allergy • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases

Experience with ALUTARD SQ Immunotherapy in Patients Allergic to Hymenoptera Venom (EAACI 2025) - No abstract available

Clinical • Immunology

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever (clinicaltrials.gov) - P3 | N=18 | Completed | Sponsor: Imperial College London | Unknown status ➔ Completed

Trial completion • Allergic Rhinitis • Immunology • Inflammation